Frozen-thawed embryo transfer (FET) cycles appear to result in better clinical pregnancy rates and obstetrical outcomes compared to fresh ET. Controlled ovarian hyperstimulation alters the hormonal environment of the endometrium, which in theory could interfere with normal gene expression and creation of an optimal window of implantation. Abnormal placentation and impaired angiogenesis in early gestation could in turn lead to developmental programming sequelae including intrauterine growth restriction and long term health consequences for offspring. Synthetic preparation for FET is designed to mimic the natural cycle and approximate the normal physiological state and potentially result in improved neonatal outcome.
A total of 81 patients were included in the study. No significant difference between birth weights and placental pathology in infants born from fresh (n= 45) versus frozen (n=36) SET. 
Conclusion(s):
Despite a subtle increase in growth based on EFW at 24 weeks gestation (744.0±103.2g vs. 633.2±154.1g, p=0.08), FET cycles were associated with birth weights at term comparable to those seen in fresh cycles. A trend towards increased histological abnormalities in placentas from fresh SET is consistent with previous studies and could be explained by supraphysiological estradiol levels occurring when embryos are transferred following controlled ovarian hyperstimulation in a fresh cycle. To our knowledge, this is the first study to directly compare placental pathology in pregnancies resulting from fresh versus frozen SET. Our findings can be used to inform clinical decision-making regarding both methods for SET, and to promote the efficacy of FET in improving obstetrical outcomes.
